61 related articles for article (PubMed ID: 25466196)
1. Targeting HER-2 over expressed breast cancer cells with 2-cyclohexyl-N-[(Z)-(substituted phenyl/furan-2-yl/thiophene-2-yl)methylidene]hydrazinecarbothioamide.
Bhat MA; Al-Dhfyan A; Khan AA; Al-Harbi N; Manogaran PS; Alanazi AM; Fun HK; Al-Omar MA
Bioorg Med Chem Lett; 2015 Jan; 25(1):83-7. PubMed ID: 25466196
[TBL] [Abstract][Full Text] [Related]
2. Lead Optimization of 2-Cyclohexyl-N-[(Z)-(3-methoxyphenyl/3-hydroxyphenyl) methylidene]hydrazinecarbothioamides for Targeting the HER-2 Overexpressed Breast Cancer Cell Line SKBr-3.
Bhat MA; Al-Dhfyan A; Naglah AM; Khan AA; Al-Omar MA
Molecules; 2015 Oct; 20(10):18246-63. PubMed ID: 26457700
[TBL] [Abstract][Full Text] [Related]
3. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
Bai T; Luoh SW
Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of HER-2 expression in human breast cancer cell HBC-4 and ZR75-1 by nitrogen-mustard-N-oxide.
Sai S; Furuya Y; Fujino Y; Kuroda Y
Kobe J Med Sci; 2007; 53(4):135-42. PubMed ID: 17932452
[TBL] [Abstract][Full Text] [Related]
7. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.
Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT
Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517
[TBL] [Abstract][Full Text] [Related]
8. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
[TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanism of proliferation of human breast cancer cell MCF-7 inhibited by E1A gene].
Chen J; Shen LF; Zhong MZ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):582-6. PubMed ID: 18667769
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of pyrimidine-based dual inhibitors of human epidermal growth factor receptor 1 (HER-1) and HER-2 tyrosine kinases.
Cha MY; Lee KO; Kang SJ; Jung YH; Song JY; Choi KJ; Byun JY; Lee HJ; Lee GS; Park SB; Kim MS
J Med Chem; 2012 Mar; 55(6):2846-57. PubMed ID: 22372864
[TBL] [Abstract][Full Text] [Related]
12. [Effect of genistein on expression of angiogenesis related factors in HER-2/neu-overexpressing breast cancer cells].
Yu XP; Mi MT; Zhu JD
Shi Yan Sheng Wu Xue Bao; 2004 Jun; 37(3):251-3. PubMed ID: 15323430
[TBL] [Abstract][Full Text] [Related]
13. Stroma cells: a novel target of herceptin activity.
Corsini C; Mancuso P; Paul S; Burlini A; Martinelli G; Pruneri G; Bertolini F
Clin Cancer Res; 2003 May; 9(5):1820-5. PubMed ID: 12738740
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and anticancer screening of some novel piperonyl-tetrazole derivatives.
Arshad M; Bhat AR; Pokharel S; Kim JE; Lee EJ; Athar F; Choi I
Eur J Med Chem; 2014 Jan; 71():229-36. PubMed ID: 24309000
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
[TBL] [Abstract][Full Text] [Related]
16. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
17. Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression.
Menendez JA; Mehmi I; Lupu R
J Clin Oncol; 2006 Aug; 24(23):3735-46. PubMed ID: 16847284
[TBL] [Abstract][Full Text] [Related]
18. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
19. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor.
Osipo C; Patel P; Rizzo P; Clementz AG; Hao L; Golde TE; Miele L
Oncogene; 2008 Aug; 27(37):5019-32. PubMed ID: 18469855
[TBL] [Abstract][Full Text] [Related]
20. Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells.
Noratto G; Porter W; Byrne D; Cisneros-Zevallos L
J Agric Food Chem; 2009 Jun; 57(12):5219-26. PubMed ID: 19530711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
